Anuncio
Mercados españoles cerrados

  • IBEX 35

    10.943,70
    -7,80 (-0,07%)
     

  • Euro Stoxx 50

    4.894,02
    -8,58 (-0,18%)
     

  • Dólar/Euro

    1,0742
    +0,0033 (+0,31%)
     

  • Petróleo Brent

    86,48
    +0,07 (+0,08%)
     

  • Oro

    2.336,90
    -2,70 (-0,12%)
     

  • Bitcoin EUR

    57.671,34
    +974,92 (+1,72%)
     

  • CMC Crypto 200

    1.291,17
    +7,34 (+0,57%)
     

  • DAX

    18.235,45
    +24,85 (+0,14%)
     

  • FTSE 100

    8.164,12
    -15,56 (-0,19%)
     

  • S&P 500

    5.460,48
    -22,39 (-0,41%)
     

  • Dow Jones

    39.118,86
    -45,24 (-0,12%)
     

  • Nasdaq

    17.732,60
    -126,10 (-0,71%)
     

  • Petróleo WTI

    81,46
    -0,08 (-0,10%)
     

  • EUR/GBP

    0,8489
    +0,0021 (+0,25%)
     

  • Plata

    29,43
    -0,12 (-0,42%)
     

  • NIKKEI 225

    39.583,08
    +241,58 (+0,61%)
     

Public advisory - One lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion recalled due to an impurity that may pose health risks

CNW Group
·2 min de lectura

OTTAWA, ON, June 28, 2024 /CNW/ -

Summary

  • Products: ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion, 60 mL (DIN 00653209, lot 688519)

  • Issue: Health products – Product quality

  • What to do: Do not use this product. Consult a health care professional if you have used this product and have health concerns. Return products to your local pharmacy for proper disposal.

ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion, 60 mL (CNW Group/Health Canada (HC))
ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion, 60 mL (CNW Group/Health Canada (HC))

Affected products

Product 

DIN

Lot

Expiry 

ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion, 60 mL

00653209

688519

06/2024

Issue

Teva Canada Ltd. is recalling one lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion in 60 mL bottles. This action follows testing that detected an impurity—betamethasone enol aldehyde—above the accepted limit in the affected lot. This impurity can form due to a chemical change in the drug during storage and may pose health risks, including the possibility of adverse reactions on the skin or elsewhere in the body from being absorbed into the bloodstream. The risk may be greater in children who may absorb proportionally larger amounts of the impurity and be more susceptible to adverse reactions.

ANUNCIO

The product is a prescription corticosteroid lotion used to relieve skin inflammation and itch caused by skin conditions such as eczema, psoriasis and dermatitis. The affected lot was distributed to pharmacies in Canada between November 24, 2022 and March 22, 2023.

Health Canada is monitoring the company's recall, and its implementation of any necessary corrective and preventative actions to prevent this issue from reoccurring.

What you should do

  • Do not use the affected product. Consult a health care professional if you have used this product and have health concerns.

  • Return the products to your local pharmacy for proper disposal.

  • Contact Teva Canada Ltd. toll-free at 1-800-268-4129 if you have questions about the recall.

  • Report any health product-related side effects or complaints to Health Canada.

Related links:

    Également disponible en français

SOURCE Health Canada (HC)

Cision
Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2024/28/c9848.html